Stay updated on Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial page.

Latest updates to the Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedPublications attribution text updated to indicate automatic population from PubMed, and the revision label updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check19 days agoChange DetectedThe site-wide government funding status notice banner was removed, leaving the standard study details visible. Core trial information and eligibility remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check34 days agoChange DetectedNo substantive changes detected in the Study Details page; the content mirrors the previous version with only formatting/administrative updates such as last updated date. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check63 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference3%

- Check70 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.1%

- Check84 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial page.